GetTopicDetailResponse(id=1ba63e26086, topicName=去甲基化藥物, introduction=去甲基化藥物, content=null, image=null, comments=2, allHits=2030, url=https://h5.medsci.cn/topic?id=37260, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=53553, tagList=[TagDto(tagId=53553, tagName=去甲基化藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2194228, encodeId=e6572194228b0, content=<a href='/topic/show?id=ed2a183e6ce' target=_blank style='color:#2F92EE;'>#venetoclax#</a> <a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a> <a href='/topic/show?id=7b468016366' target=_blank style='color:#2F92EE;'>#老年急性髓系白血病#</a> <a href='/topic/show?id=98ef112469b8' target=_blank style='color:#2F92EE;'>#系統(tǒng)性綜述和薈萃分析#</a>, objectTitle=Eur Rev Med Pharmacol Sci：venetoclax聯(lián)合去甲基化藥物治療老年急性髓系白血病的療效和安全性：系統(tǒng)性綜述和薈萃分析, objectType=article, longId=817526, objectId=83c681e5268c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668018121539_4754896.png, objectUrl=/article/show_article.do?id=83c681e5268c, replyNumber=1, likeNumber=96, createdTime=2024-03-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=83c681e5268c, moduleTitle=Eur Rev Med Pharmacol Sci：venetoclax聯(lián)合去甲基化藥物治療老年急性髓系白血病的療效和安全性：系統(tǒng)性綜述和薈萃分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83c681e5268c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2092383, encodeId=737420923831f, content=<a href='/topic/show?id=cfd353291f3' target=_blank style='color:#2F92EE;'>#感染#</a>與<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生異常綜合征#</a>、<a href='/topic/show?id=7e301049039f' target=_blank style='color:#2F92EE;'>#慢性骨髓單核細(xì)胞白血病#</a>和使用<a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a>治療的<a href='/topic/show?id=51c2104904e1' target=_blank style='color:#2F92EE;'>#急性骨髓白血病#</a>患者預(yù)后的相關(guān)性，血液系統(tǒng)疾病的治療預(yù)防感染十分重要, objectTitle=Ther Adv Hematol：感染與骨髓增生異常綜合征、慢性骨髓單核細(xì)胞白血病和使用低甲基化藥物治療的急性骨髓白血病患者預(yù)后的相關(guān)性, objectType=article, longId=741925, objectId=da82e41925c2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=da82e41925c2, replyNumber=0, likeNumber=136, createdTime=2022-10-07, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da82e41925c2, moduleTitle=Ther Adv Hematol：感染與骨髓增生異常綜合征、慢性骨髓單核細(xì)胞白血病和使用低甲基化藥物治療的急性骨髓白血病患者預(yù)后的相關(guān)性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=da82e41925c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241612, encodeId=e7821241612f6, content=<a href='/topic/show?id=1ba63e26086' target=_blank style='color:#2F92EE;'>#去甲基化藥物#</a><a href='/topic/show?id=2d4c4140296' target=_blank style='color:#2F92EE;'>#地西他濱#</a>克服<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌癥#</a>患者對<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治療#</a>產(chǎn)生的耐受作用, objectTitle=J Immunother Cancer：去甲基化藥物地西他濱克服癌癥患者對免疫治療產(chǎn)生的耐受作用, objectType=article, longId=736931, objectId=37c8e36931bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220823/69c0fcd255a847fc96b6272dcaf6730a.jpg, objectUrl=/article/show_article.do?id=37c8e36931bd, replyNumber=0, likeNumber=195, createdTime=2022-08-28, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c8e36931bd, moduleTitle=J Immunother Cancer：去甲基化藥物地西他濱克服癌癥患者對免疫治療產(chǎn)生的耐受作用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=37c8e36931bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
